This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
This is a web analytics service.
Processing company
  • Zoom Analytics Ltd.
  • Petah Tikva, Israel
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
CEO of Stada Group Visited Hemofarm
19. June 2020.
Shortly after easing of the security measures across the Stada Group, CEO Peter Goldschmidt visited Hemofarm's headquarters in Vršac. As he pointed out during the tour of the production facilities, the main reason of his visit was not business, but a desire to thank in person to all the employees who worked around the clock enabling the patients not to worry about their therapy even in the most challenging times. This visit was organized shortly after celebration of the 60th anniversary of Hemofarm and it was a chance for the company management to meet again with the employees and discuss the further plans.

Apart from meeting with the company management and visiting Hemofarm’s factory in Vršac, the leading man of Stada had a chance during this visit to talk to several leading editors and economic journalists in Serbia.

Generalni direktor Štada grupe posetio Hemofarm

’The reason of my visit was not business, but I came to thank the employees in Serbia! They worked more than ever during the pandemic, and our production plants were not closed even for an hour. Serbs have demonstrated how efficient they are. Hemofarm is one of our biggest plants in terms of employee number, as well as our most important manufacturing site. On this occasion, I wanted to express my gratitude on behalf of other countries, because due to the great work of the Serbian company, also patients in Germany, Russia and other countries received medicines on time’, was the answer of the CEO of Stada when asked by the Serbian journalists about the reason of his visit to Serbia.

Asked whether companies in Europe will be under pressure of their governments to bring back the production to their countries since coronavirus demonstrated that there were problems in the supply chain especially when suppliers from other continents were concerned, Goldschmidt answered that such types of requests were to be expected, but they were not realistic or enforceable. ’Hemofarm is a good example how everything can function well, although the company is based outside Germany. The factory from Vršac produces medicines of the highest European quality, they are intended to patients from all around the world and it proved even during the present crisis that the regular supply was possible to meet.’

Asked whether, despite the current crisis caused by the pandemic, Stada will continue the planned investment in Hemofarm, Goldschmidt answered in the affirmative. During the one-hour talks with the journalists, the CEO of Stada answered also the questions about the consequences of the pandemic to the global pharmaceutical industry, whether Europe and Germany will face the recession which can influence also the business operations of Stada, about significance of the discovery of a vaccine against the coronavirus etc.